Answers are grounded in this paper and cite their sources.
Case report demonstrates successful symptom management with perampanel in GRIA1-related epilepsy and intellectual disability, highlighting precision medicine for rare neurodevelopmental disorders.
Objectives: pathogenic variant presenting with intellectual disability (ID) and epilepsy. We describe clinical features, genetic findings, a personalized treatment approach, and a literature review of GRIA1-related disorders. Methods: We describe clinical presentation, neuropsychological assessment, and genetic analysis. We conducted a literature review of published GRIA1-related disorders using PubMed, Simons Foundation Autism Research Initiative (SFARI) Gene, and ClinVar databases. Discussion: This case emphasizes the role of targeted interventions in the management of rare genetic disorders and underscores the potential of precision medicine in addressing GRIA1-related symptoms.
No takes yet. Share an insight, caveat, or question.
Cesaroni et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: